BMJ Open:厉害了,word太极!可有效治疗创伤后应激障碍

2016-12-06 MedSci MedSci原创

创伤后应激障碍(PTSD)是一种心理健康疾病,通常发生在经历或目睹一个令人震惊或可怕的事件之后。约7-8%的美国人会经历PTSD,以退伍军人尤甚,约23%的退伍军人受PTSD的困扰。PTSD的治疗通常包括药物和行为疗法,然而,这些治疗并不总是有效的。近日,来自马萨诸塞州波士顿大学医学院的一项新的研究表明,中国的一种古老的运动-太极,可有效帮助退伍军人管理其PTSD的症状,其研究结果已发表于BMJ

创伤后应激障碍(PTSD)是一种心理健康疾病,通常发生在经历或目睹一个令人震惊或可怕的事件之后。约7-8%的美国人会经历PTSD,以退伍军人尤甚,约23%的退伍军人受PTSD的困扰。PTSD的治疗通常包括药物和行为疗法,然而,这些治疗并不总是有效的。

近日,来自马萨诸塞州波士顿大学医学院的一项新的研究表明,中国的一种古老的运动-太极,可有效帮助退伍军人管理其PTSD的症状,其研究结果已发表于BMJ Open

太极拳是中国国家级非物质文化遗产, 以中国传统儒、道哲学中的太极、阴阳辩证理念为核心思想,集颐养性情、强身健体、技击对抗等多种功能为一体,结合易学的阴阳五行之变化,中医经络学,古代的导引术和吐纳术形成的一种内外兼修、柔和、缓慢、轻灵、刚柔相济的汉族传统拳术。

既往研究已发现练习太极的多个健康益处,包括改善肌肉力量,增加能量,减少炎症,以及有益于心脏健康等。还有研究表明,练习太极有益于机体的心理健康,如减少焦虑和等。但是目前并没有研究探究练习太极是否有益于PTSD患者的症状管理。

本研究中,研究人员招募了17名存在PTSD症状的退伍军人(11名男性和6名女性),参与太极练习计划,每周一次练习课程,练习4周以上。

每次练习课程都包括一个热身(包括自我按摩和回顾太极的原则),太极运动,呼吸和放松。在此4周的练习期间,同时鼓励所有参与者每天在家至少练习太极30分钟。

最后一次课程完成之后,每名参与者完成了一份问卷,问卷内容包括对太极练习项目的满意度,未来是否愿意继续参与太极练习项目,以及太极是否有助于其PTSD症状的管理。

93.8%的参与者非常/极其满意太极练习项目,对太极项目的评级为“优秀”或“好”。更重要的是,68.8%的参与者表示太极项目有助于更好的管理其PTSD症状,并表示希望继续参加未来的太极项目。

但是该研究的样本量较小,且一些参与者仅为轻度PTSD,因此该研究结果或并不能适用于更大的退伍军人及更重的PTSD患者。

不过,研究人员表示,该研究结果为患有PTSD的退伍军人练习太极来管理其症状提供了新的证据支持。未来仍需更多的研究以进一步评价太极治疗PTSD症状的有效性。

原始出处:

[1] Honor Whiteman. Tai Chi may benefit veterans with PTSD. MNT, 6 December 2016.

[2] Barbara Niles et al., Feasibility, qualitative findings and satisfaction of a brief Tai Chi mind–body programme for veterans with post-traumatic stress symptoms. BMJ Open. 29 November 2016.


本文系梅斯医学MedSci原创编译整理转载需授权

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (8)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1726243, encodeId=cf1a1e26243a4, content=<a href='/topic/show?id=986913980dd' target=_blank style='color:#2F92EE;'>#PE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13980, encryptionId=986913980dd, topicName=PE)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f06c33759375, createdName=feather89, createdTime=Fri Feb 17 06:48:00 CST 2017, time=2017-02-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1632117, encodeId=4a80163211e88, content=<a href='/topic/show?id=34c74421593' target=_blank style='color:#2F92EE;'>#太极#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=44215, encryptionId=34c74421593, topicName=太极)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ec5221859655, createdName=steven_u9, createdTime=Mon Mar 27 00:48:00 CST 2017, time=2017-03-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1848184, encodeId=310a1848184aa, content=<a href='/topic/show?id=2977356edc' target=_blank style='color:#2F92EE;'>#BMJ#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3567, encryptionId=2977356edc, topicName=BMJ)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=148754, createdName=gaoxiaoe, createdTime=Fri Oct 27 11:48:00 CST 2017, time=2017-10-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2019999, encodeId=066f20199999b, content=<a href='/topic/show?id=365518e5883' target=_blank style='color:#2F92EE;'>#Word#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=18758, encryptionId=365518e5883, topicName=Word)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=aa5a2500103, createdName=ms920641618706883, createdTime=Sat Jul 15 14:48:00 CST 2017, time=2017-07-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1335123, encodeId=d8a91335123de, content=<a href='/topic/show?id=e7cc32022c7' target=_blank style='color:#2F92EE;'>#创伤#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=32022, encryptionId=e7cc32022c7, topicName=创伤)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=aa5a2500103, createdName=ms920641618706883, createdTime=Thu Dec 08 04:48:00 CST 2016, time=2016-12-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1445132, encodeId=833f14451325d, content=<a href='/topic/show?id=61e74928629' target=_blank style='color:#2F92EE;'>#应激#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=49286, encryptionId=61e74928629, topicName=应激)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=医者仁心, createdTime=Thu Dec 08 04:48:00 CST 2016, time=2016-12-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1619452, encodeId=8c0916194520a, content=<a href='/topic/show?id=8dd46061824' target=_blank style='color:#2F92EE;'>#有效治疗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=60618, encryptionId=8dd46061824, topicName=有效治疗)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a12645, createdName=docwu2019, createdTime=Thu Dec 08 04:48:00 CST 2016, time=2016-12-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=160708, encodeId=6350160e089f, content=我很久之前就想练了, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=90f31612316, createdName=xiaotaiyang1, createdTime=Tue Dec 06 15:27:39 CST 2016, time=2016-12-06, status=1, ipAttribution=)]
    2017-02-17 feather89
  2. [GetPortalCommentsPageByObjectIdResponse(id=1726243, encodeId=cf1a1e26243a4, content=<a href='/topic/show?id=986913980dd' target=_blank style='color:#2F92EE;'>#PE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13980, encryptionId=986913980dd, topicName=PE)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f06c33759375, createdName=feather89, createdTime=Fri Feb 17 06:48:00 CST 2017, time=2017-02-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1632117, encodeId=4a80163211e88, content=<a href='/topic/show?id=34c74421593' target=_blank style='color:#2F92EE;'>#太极#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=44215, encryptionId=34c74421593, topicName=太极)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ec5221859655, createdName=steven_u9, createdTime=Mon Mar 27 00:48:00 CST 2017, time=2017-03-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1848184, encodeId=310a1848184aa, content=<a href='/topic/show?id=2977356edc' target=_blank style='color:#2F92EE;'>#BMJ#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3567, encryptionId=2977356edc, topicName=BMJ)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=148754, createdName=gaoxiaoe, createdTime=Fri Oct 27 11:48:00 CST 2017, time=2017-10-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2019999, encodeId=066f20199999b, content=<a href='/topic/show?id=365518e5883' target=_blank style='color:#2F92EE;'>#Word#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=18758, encryptionId=365518e5883, topicName=Word)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=aa5a2500103, createdName=ms920641618706883, createdTime=Sat Jul 15 14:48:00 CST 2017, time=2017-07-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1335123, encodeId=d8a91335123de, content=<a href='/topic/show?id=e7cc32022c7' target=_blank style='color:#2F92EE;'>#创伤#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=32022, encryptionId=e7cc32022c7, topicName=创伤)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=aa5a2500103, createdName=ms920641618706883, createdTime=Thu Dec 08 04:48:00 CST 2016, time=2016-12-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1445132, encodeId=833f14451325d, content=<a href='/topic/show?id=61e74928629' target=_blank style='color:#2F92EE;'>#应激#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=49286, encryptionId=61e74928629, topicName=应激)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=医者仁心, createdTime=Thu Dec 08 04:48:00 CST 2016, time=2016-12-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1619452, encodeId=8c0916194520a, content=<a href='/topic/show?id=8dd46061824' target=_blank style='color:#2F92EE;'>#有效治疗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=60618, encryptionId=8dd46061824, topicName=有效治疗)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a12645, createdName=docwu2019, createdTime=Thu Dec 08 04:48:00 CST 2016, time=2016-12-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=160708, encodeId=6350160e089f, content=我很久之前就想练了, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=90f31612316, createdName=xiaotaiyang1, createdTime=Tue Dec 06 15:27:39 CST 2016, time=2016-12-06, status=1, ipAttribution=)]
    2017-03-27 steven_u9
  3. [GetPortalCommentsPageByObjectIdResponse(id=1726243, encodeId=cf1a1e26243a4, content=<a href='/topic/show?id=986913980dd' target=_blank style='color:#2F92EE;'>#PE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13980, encryptionId=986913980dd, topicName=PE)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f06c33759375, createdName=feather89, createdTime=Fri Feb 17 06:48:00 CST 2017, time=2017-02-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1632117, encodeId=4a80163211e88, content=<a href='/topic/show?id=34c74421593' target=_blank style='color:#2F92EE;'>#太极#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=44215, encryptionId=34c74421593, topicName=太极)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ec5221859655, createdName=steven_u9, createdTime=Mon Mar 27 00:48:00 CST 2017, time=2017-03-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1848184, encodeId=310a1848184aa, content=<a href='/topic/show?id=2977356edc' target=_blank style='color:#2F92EE;'>#BMJ#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3567, encryptionId=2977356edc, topicName=BMJ)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=148754, createdName=gaoxiaoe, createdTime=Fri Oct 27 11:48:00 CST 2017, time=2017-10-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2019999, encodeId=066f20199999b, content=<a href='/topic/show?id=365518e5883' target=_blank style='color:#2F92EE;'>#Word#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=18758, encryptionId=365518e5883, topicName=Word)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=aa5a2500103, createdName=ms920641618706883, createdTime=Sat Jul 15 14:48:00 CST 2017, time=2017-07-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1335123, encodeId=d8a91335123de, content=<a href='/topic/show?id=e7cc32022c7' target=_blank style='color:#2F92EE;'>#创伤#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=32022, encryptionId=e7cc32022c7, topicName=创伤)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=aa5a2500103, createdName=ms920641618706883, createdTime=Thu Dec 08 04:48:00 CST 2016, time=2016-12-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1445132, encodeId=833f14451325d, content=<a href='/topic/show?id=61e74928629' target=_blank style='color:#2F92EE;'>#应激#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=49286, encryptionId=61e74928629, topicName=应激)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=医者仁心, createdTime=Thu Dec 08 04:48:00 CST 2016, time=2016-12-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1619452, encodeId=8c0916194520a, content=<a href='/topic/show?id=8dd46061824' target=_blank style='color:#2F92EE;'>#有效治疗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=60618, encryptionId=8dd46061824, topicName=有效治疗)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a12645, createdName=docwu2019, createdTime=Thu Dec 08 04:48:00 CST 2016, time=2016-12-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=160708, encodeId=6350160e089f, content=我很久之前就想练了, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=90f31612316, createdName=xiaotaiyang1, createdTime=Tue Dec 06 15:27:39 CST 2016, time=2016-12-06, status=1, ipAttribution=)]
    2017-10-27 gaoxiaoe
  4. [GetPortalCommentsPageByObjectIdResponse(id=1726243, encodeId=cf1a1e26243a4, content=<a href='/topic/show?id=986913980dd' target=_blank style='color:#2F92EE;'>#PE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13980, encryptionId=986913980dd, topicName=PE)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f06c33759375, createdName=feather89, createdTime=Fri Feb 17 06:48:00 CST 2017, time=2017-02-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1632117, encodeId=4a80163211e88, content=<a href='/topic/show?id=34c74421593' target=_blank style='color:#2F92EE;'>#太极#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=44215, encryptionId=34c74421593, topicName=太极)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ec5221859655, createdName=steven_u9, createdTime=Mon Mar 27 00:48:00 CST 2017, time=2017-03-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1848184, encodeId=310a1848184aa, content=<a href='/topic/show?id=2977356edc' target=_blank style='color:#2F92EE;'>#BMJ#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3567, encryptionId=2977356edc, topicName=BMJ)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=148754, createdName=gaoxiaoe, createdTime=Fri Oct 27 11:48:00 CST 2017, time=2017-10-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2019999, encodeId=066f20199999b, content=<a href='/topic/show?id=365518e5883' target=_blank style='color:#2F92EE;'>#Word#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=18758, encryptionId=365518e5883, topicName=Word)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=aa5a2500103, createdName=ms920641618706883, createdTime=Sat Jul 15 14:48:00 CST 2017, time=2017-07-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1335123, encodeId=d8a91335123de, content=<a href='/topic/show?id=e7cc32022c7' target=_blank style='color:#2F92EE;'>#创伤#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=32022, encryptionId=e7cc32022c7, topicName=创伤)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=aa5a2500103, createdName=ms920641618706883, createdTime=Thu Dec 08 04:48:00 CST 2016, time=2016-12-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1445132, encodeId=833f14451325d, content=<a href='/topic/show?id=61e74928629' target=_blank style='color:#2F92EE;'>#应激#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=49286, encryptionId=61e74928629, topicName=应激)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=医者仁心, createdTime=Thu Dec 08 04:48:00 CST 2016, time=2016-12-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1619452, encodeId=8c0916194520a, content=<a href='/topic/show?id=8dd46061824' target=_blank style='color:#2F92EE;'>#有效治疗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=60618, encryptionId=8dd46061824, topicName=有效治疗)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a12645, createdName=docwu2019, createdTime=Thu Dec 08 04:48:00 CST 2016, time=2016-12-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=160708, encodeId=6350160e089f, content=我很久之前就想练了, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=90f31612316, createdName=xiaotaiyang1, createdTime=Tue Dec 06 15:27:39 CST 2016, time=2016-12-06, status=1, ipAttribution=)]
  5. [GetPortalCommentsPageByObjectIdResponse(id=1726243, encodeId=cf1a1e26243a4, content=<a href='/topic/show?id=986913980dd' target=_blank style='color:#2F92EE;'>#PE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13980, encryptionId=986913980dd, topicName=PE)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f06c33759375, createdName=feather89, createdTime=Fri Feb 17 06:48:00 CST 2017, time=2017-02-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1632117, encodeId=4a80163211e88, content=<a href='/topic/show?id=34c74421593' target=_blank style='color:#2F92EE;'>#太极#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=44215, encryptionId=34c74421593, topicName=太极)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ec5221859655, createdName=steven_u9, createdTime=Mon Mar 27 00:48:00 CST 2017, time=2017-03-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1848184, encodeId=310a1848184aa, content=<a href='/topic/show?id=2977356edc' target=_blank style='color:#2F92EE;'>#BMJ#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3567, encryptionId=2977356edc, topicName=BMJ)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=148754, createdName=gaoxiaoe, createdTime=Fri Oct 27 11:48:00 CST 2017, time=2017-10-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2019999, encodeId=066f20199999b, content=<a href='/topic/show?id=365518e5883' target=_blank style='color:#2F92EE;'>#Word#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=18758, encryptionId=365518e5883, topicName=Word)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=aa5a2500103, createdName=ms920641618706883, createdTime=Sat Jul 15 14:48:00 CST 2017, time=2017-07-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1335123, encodeId=d8a91335123de, content=<a href='/topic/show?id=e7cc32022c7' target=_blank style='color:#2F92EE;'>#创伤#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=32022, encryptionId=e7cc32022c7, topicName=创伤)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=aa5a2500103, createdName=ms920641618706883, createdTime=Thu Dec 08 04:48:00 CST 2016, time=2016-12-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1445132, encodeId=833f14451325d, content=<a href='/topic/show?id=61e74928629' target=_blank style='color:#2F92EE;'>#应激#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=49286, encryptionId=61e74928629, topicName=应激)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=医者仁心, createdTime=Thu Dec 08 04:48:00 CST 2016, time=2016-12-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1619452, encodeId=8c0916194520a, content=<a href='/topic/show?id=8dd46061824' target=_blank style='color:#2F92EE;'>#有效治疗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=60618, encryptionId=8dd46061824, topicName=有效治疗)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a12645, createdName=docwu2019, createdTime=Thu Dec 08 04:48:00 CST 2016, time=2016-12-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=160708, encodeId=6350160e089f, content=我很久之前就想练了, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=90f31612316, createdName=xiaotaiyang1, createdTime=Tue Dec 06 15:27:39 CST 2016, time=2016-12-06, status=1, ipAttribution=)]
  6. [GetPortalCommentsPageByObjectIdResponse(id=1726243, encodeId=cf1a1e26243a4, content=<a href='/topic/show?id=986913980dd' target=_blank style='color:#2F92EE;'>#PE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13980, encryptionId=986913980dd, topicName=PE)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f06c33759375, createdName=feather89, createdTime=Fri Feb 17 06:48:00 CST 2017, time=2017-02-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1632117, encodeId=4a80163211e88, content=<a href='/topic/show?id=34c74421593' target=_blank style='color:#2F92EE;'>#太极#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=44215, encryptionId=34c74421593, topicName=太极)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ec5221859655, createdName=steven_u9, createdTime=Mon Mar 27 00:48:00 CST 2017, time=2017-03-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1848184, encodeId=310a1848184aa, content=<a href='/topic/show?id=2977356edc' target=_blank style='color:#2F92EE;'>#BMJ#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3567, encryptionId=2977356edc, topicName=BMJ)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=148754, createdName=gaoxiaoe, createdTime=Fri Oct 27 11:48:00 CST 2017, time=2017-10-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2019999, encodeId=066f20199999b, content=<a href='/topic/show?id=365518e5883' target=_blank style='color:#2F92EE;'>#Word#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=18758, encryptionId=365518e5883, topicName=Word)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=aa5a2500103, createdName=ms920641618706883, createdTime=Sat Jul 15 14:48:00 CST 2017, time=2017-07-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1335123, encodeId=d8a91335123de, content=<a href='/topic/show?id=e7cc32022c7' target=_blank style='color:#2F92EE;'>#创伤#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=32022, encryptionId=e7cc32022c7, topicName=创伤)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=aa5a2500103, createdName=ms920641618706883, createdTime=Thu Dec 08 04:48:00 CST 2016, time=2016-12-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1445132, encodeId=833f14451325d, content=<a href='/topic/show?id=61e74928629' target=_blank style='color:#2F92EE;'>#应激#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=49286, encryptionId=61e74928629, topicName=应激)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=医者仁心, createdTime=Thu Dec 08 04:48:00 CST 2016, time=2016-12-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1619452, encodeId=8c0916194520a, content=<a href='/topic/show?id=8dd46061824' target=_blank style='color:#2F92EE;'>#有效治疗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=60618, encryptionId=8dd46061824, topicName=有效治疗)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a12645, createdName=docwu2019, createdTime=Thu Dec 08 04:48:00 CST 2016, time=2016-12-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=160708, encodeId=6350160e089f, content=我很久之前就想练了, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=90f31612316, createdName=xiaotaiyang1, createdTime=Tue Dec 06 15:27:39 CST 2016, time=2016-12-06, status=1, ipAttribution=)]
  7. [GetPortalCommentsPageByObjectIdResponse(id=1726243, encodeId=cf1a1e26243a4, content=<a href='/topic/show?id=986913980dd' target=_blank style='color:#2F92EE;'>#PE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13980, encryptionId=986913980dd, topicName=PE)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f06c33759375, createdName=feather89, createdTime=Fri Feb 17 06:48:00 CST 2017, time=2017-02-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1632117, encodeId=4a80163211e88, content=<a href='/topic/show?id=34c74421593' target=_blank style='color:#2F92EE;'>#太极#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=44215, encryptionId=34c74421593, topicName=太极)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ec5221859655, createdName=steven_u9, createdTime=Mon Mar 27 00:48:00 CST 2017, time=2017-03-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1848184, encodeId=310a1848184aa, content=<a href='/topic/show?id=2977356edc' target=_blank style='color:#2F92EE;'>#BMJ#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3567, encryptionId=2977356edc, topicName=BMJ)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=148754, createdName=gaoxiaoe, createdTime=Fri Oct 27 11:48:00 CST 2017, time=2017-10-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2019999, encodeId=066f20199999b, content=<a href='/topic/show?id=365518e5883' target=_blank style='color:#2F92EE;'>#Word#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=18758, encryptionId=365518e5883, topicName=Word)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=aa5a2500103, createdName=ms920641618706883, createdTime=Sat Jul 15 14:48:00 CST 2017, time=2017-07-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1335123, encodeId=d8a91335123de, content=<a href='/topic/show?id=e7cc32022c7' target=_blank style='color:#2F92EE;'>#创伤#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=32022, encryptionId=e7cc32022c7, topicName=创伤)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=aa5a2500103, createdName=ms920641618706883, createdTime=Thu Dec 08 04:48:00 CST 2016, time=2016-12-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1445132, encodeId=833f14451325d, content=<a href='/topic/show?id=61e74928629' target=_blank style='color:#2F92EE;'>#应激#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=49286, encryptionId=61e74928629, topicName=应激)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=医者仁心, createdTime=Thu Dec 08 04:48:00 CST 2016, time=2016-12-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1619452, encodeId=8c0916194520a, content=<a href='/topic/show?id=8dd46061824' target=_blank style='color:#2F92EE;'>#有效治疗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=60618, encryptionId=8dd46061824, topicName=有效治疗)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a12645, createdName=docwu2019, createdTime=Thu Dec 08 04:48:00 CST 2016, time=2016-12-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=160708, encodeId=6350160e089f, content=我很久之前就想练了, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=90f31612316, createdName=xiaotaiyang1, createdTime=Tue Dec 06 15:27:39 CST 2016, time=2016-12-06, status=1, ipAttribution=)]
  8. [GetPortalCommentsPageByObjectIdResponse(id=1726243, encodeId=cf1a1e26243a4, content=<a href='/topic/show?id=986913980dd' target=_blank style='color:#2F92EE;'>#PE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13980, encryptionId=986913980dd, topicName=PE)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f06c33759375, createdName=feather89, createdTime=Fri Feb 17 06:48:00 CST 2017, time=2017-02-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1632117, encodeId=4a80163211e88, content=<a href='/topic/show?id=34c74421593' target=_blank style='color:#2F92EE;'>#太极#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=44215, encryptionId=34c74421593, topicName=太极)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ec5221859655, createdName=steven_u9, createdTime=Mon Mar 27 00:48:00 CST 2017, time=2017-03-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1848184, encodeId=310a1848184aa, content=<a href='/topic/show?id=2977356edc' target=_blank style='color:#2F92EE;'>#BMJ#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3567, encryptionId=2977356edc, topicName=BMJ)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=148754, createdName=gaoxiaoe, createdTime=Fri Oct 27 11:48:00 CST 2017, time=2017-10-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2019999, encodeId=066f20199999b, content=<a href='/topic/show?id=365518e5883' target=_blank style='color:#2F92EE;'>#Word#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=18758, encryptionId=365518e5883, topicName=Word)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=aa5a2500103, createdName=ms920641618706883, createdTime=Sat Jul 15 14:48:00 CST 2017, time=2017-07-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1335123, encodeId=d8a91335123de, content=<a href='/topic/show?id=e7cc32022c7' target=_blank style='color:#2F92EE;'>#创伤#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=32022, encryptionId=e7cc32022c7, topicName=创伤)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=aa5a2500103, createdName=ms920641618706883, createdTime=Thu Dec 08 04:48:00 CST 2016, time=2016-12-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1445132, encodeId=833f14451325d, content=<a href='/topic/show?id=61e74928629' target=_blank style='color:#2F92EE;'>#应激#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=49286, encryptionId=61e74928629, topicName=应激)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=医者仁心, createdTime=Thu Dec 08 04:48:00 CST 2016, time=2016-12-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1619452, encodeId=8c0916194520a, content=<a href='/topic/show?id=8dd46061824' target=_blank style='color:#2F92EE;'>#有效治疗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=60618, encryptionId=8dd46061824, topicName=有效治疗)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a12645, createdName=docwu2019, createdTime=Thu Dec 08 04:48:00 CST 2016, time=2016-12-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=160708, encodeId=6350160e089f, content=我很久之前就想练了, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=90f31612316, createdName=xiaotaiyang1, createdTime=Tue Dec 06 15:27:39 CST 2016, time=2016-12-06, status=1, ipAttribution=)]
    2016-12-06 xiaotaiyang1

    我很久之前就想练了

    0

相关资讯

CHEST:OSA综合征严重影响创伤后应激障碍患者的症状和生活质量

研究人员试图确定OSA综合征(OSAS)对于创伤后应激障碍(PTSD)患者的症状和生活质量(QOL)的影响。此外,研究人员还评估了在该人群中气道正压(PAP)的治疗的依从性和响应。这是在学术军事医疗中心的睡眠障碍中心进行的病例对照观察性队列研究。200例连续PTSD患者接受睡眠评估。研究人员对患有PTSD并有和没有OSAS的患者与50名连续年龄匹配的患友OSAS但无PTSD患者和50名年龄匹配的正

JAMA:正念减压治疗能否帮助创伤后应激障碍患者走出阴影?

正念减压(MBSR)由美国麻省大学医学中心的Jon  Kabatzinn博士所创立,用于辅助(而非取代)一般的医疗行为,参与疗程的病患通常各自患有不同的生理或心理疾病,MBSR旨在教导病患运用自己内在的身心力量,为自己的身心健康积极地做一些他人无法替代的事——培育正念。对于存在创伤后应激障碍(PTSD)的退伍军人来说,其对现存循证治疗的依从性较差,以正念为基础的干预措施也许更易被其接受。

Psychological Sci:新奇!俄罗斯方块竟能治疗创伤后应激障碍!

速来围观!俄罗斯方块竟能有效治疗创伤后应激障碍! 对于患有创伤后应激障碍的患者,不必要的回忆是其常见症状的表现。但是最新的一项研究表明,创伤发生24小时后玩玩电脑游戏可以减小这种症状的发生。据估计,每年大约7-8%的美国人可因在生活中经历创伤,而后产生应激障碍(PTSD),而女性比男性更易发展为PTSD。PTSD是由于个体暴露于巨大创伤事件中引起的,其症状包括精神紧张、睡眠障碍、

BMJ Open:创伤后应激障碍与心血管疾病事件相关

目的:创伤后应激障碍(PTSD)是心血管疾病(CVD)的危险因素。然而,另一种常见的应激障碍调节障碍与心血管疾病的风险增加是否相关,以及这种相关是否存在性别差异。本研究的目的是调查创伤后应激障碍和及调节障碍和4个心血管事件之间的整体和性别分层的相关性。设计:利用丹麦国家注册数据的一项前瞻性队列研究。设置:丹麦总人口。参与者:1995到2011年间,创伤后应激障碍(n = 4724)和调节障碍(N

妹子们请注意:精神创伤可能让你食物成瘾

        图片来源:livescience.com 最新研究结果表明,有创伤后应激障碍(posttraumatic stress disorder, 简称PTSD)症状的女性可能更容易食物成瘾,或者对食物产生依赖感。 研究人员对49000多名25-42岁的女护士进行了调查研究,询问她们是否经历过童年受虐待

Nature:创伤后应激障碍或与基因有关

大多数人能逐渐从创伤中恢复,但一小部分人会患创伤后应激障碍(PTSD)——对严重创伤(例如战争、车祸、自然灾害)的一种极端反应。科学家一直在寻找该病的生物学基础。近日发表于美国《国家科学院院刊》的一项针对老鼠的研究指出,多达334种基因可能会导致个体易受创伤后压力影响。研究人员让约100只老鼠暴露在脏乱的猫砂环境中——使其担心捕食者的存在,并在一周后检测创伤对老鼠的影响。约1/4的老鼠被归类为“极